Subcutaneous Dasiglucagon Use During Exercise In People With Type 1 Diabetes: Effects On Plasma Glucose And Exercise Metabolism
Latest Information Update: 04 Sep 2023
At a glance
- Drugs Dasiglucagon (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 30 Aug 2023 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 19 May 2022 Planned End Date changed from 1 Jun 2021 to 1 Jun 2024.
- 19 May 2022 Planned primary completion date changed from 1 Apr 2021 to 1 Apr 2024.